Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 741 Jan 1 – Oct 24, 2026
- Disclosed funding
- $25.3B 605 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| T TensiveCompany profile Clinical-stage bioresorbable implants designed to support natural breast-tissue regeneration and mark the tumour bed after lumpectomy. Clinical-stage bioresorbable implants designed to support natural breast-tissue regeneration and mark the tumour bed after lumpectomy. | ≤€20M | Convertible venture debtUndisclosed | Healthtech | Italy | Investors | |
| HR Hi RasmusCompany profile Hi Rasmus provides an ABA-focused clinical platform for behavioral-health organizations, schools, practitioners, and families. Hi Rasmus provides an ABA-focused clinical platform for behavioral-health organizations, schools, practitioners, and families. | $50M | Strategic minority investmentUndisclosed | Healthtech | United States | Investors | |
| KA Konko AICompany profile Konko AI builds Kora, a patient-communications assistant for clinics and hospitals. Konko AI builds Kora, a patient-communications assistant for clinics and hospitals. | $6M | FundingUndisclosed | Healthtech | United States | Investors | |
| NM N-Power MedicineCompany profile N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. | $32M | Series B | Healthtech | United States | Investors | |
| E ElucidCompany profile Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk. Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk. | $55M | Series DSeries C+ | Healthtech | United States | Investors | |
| OO Outcomes OneCompany profile Outcomes One connects pharmacies, health plans, and drug manufacturers through clinical-care programs and pharmacy workflow software. Outcomes One connects pharmacies, health plans, and drug manufacturers through clinical-care programs and pharmacy workflow software. | Undisclosed | Growth investmentGrowth | Healthtech | United States | Investors | |
| E EnhanceCompany profile A SaaS operating system for gym chains that manages personal-training schedules, trainer performance, member bookings and PT revenue across multiple locations. A SaaS operating system for gym chains that manages personal-training schedules, trainer performance, member bookings and PT revenue across multiple locations. | $18.2M | Equity and venture-debt roundGrowth | Healthtech, Enterprise software | United Arab Emirates | Investors | |
| D DocPharmaCompany profile A healthcare fulfilment network connecting medicine inventory, licensed distribution and last-mile delivery for healthcare businesses. A healthcare fulfilment network connecting medicine inventory, licensed distribution and last-mile delivery for healthcare businesses. | $2M | Pre-Series AUndisclosed | Healthtech, Logistics | India | Investors | |
| i iPremomCompany profile iPremom offers MaiRa, a clinician-prescribed prenatal blood test that estimates a pregnant woman’s risk of preeclampsia from week 9. It analyzes cell-free RNA in maternal blood with a proprietary predictive algorithm, giving obstetric teams an early risk report to guide monitoring and preventive decisions; it is a risk-assessment tool, not a diagnostic test. iPremom offers MaiRa, a clinician-prescribed prenatal blood test that estimates a pregnant woman’s risk of preeclampsia from week 9. It analyzes cell-free RNA in maternal blood with a proprietary predictive algorithm, giving obstetric teams an early risk report to guide monitoring and preventive decisions; it is a risk-assessment tool, not a diagnostic test. | €15M | Seed | Healthtech | Spain | Investors | |
| TC Thyme CareCompany profile Thyme Care combines oncology-trained care teams and technology to support people through cancer treatment while helping health plans and providers improve outcomes and control costs. It monitors patient needs between appointments, coordinates with oncologists and connects members to clinical, practical and social support. Thyme Care combines oncology-trained care teams and technology to support people through cancer treatment while helping health plans and providers improve outcomes and control costs. It monitors patient needs between appointments, coordinates with oncologists and connects members to clinical, practical and social support. | >$125M | Series ESeries C+ | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.